Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence

Objective: Recently, a vaccine with the capacity to protect against serogroup B meningococcal (MenB) disease received a positive opinion of the European Medicines Agency. Previously, such a vaccine was estimated to be cost-effective. However, since then, the MenB disease incidence has declined drast...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Pouwels, Koen B., Hak, Eelko, van der Ende, Arie, Christensen, Hannah, van den Dobbelsteen, Germie P.J.M., Postma, Maarten J.
Формат: Artigo
Язык:Inglês
Опубликовано: Landes Bioscience 2013
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899149/
https://ncbi.nlm.nih.gov/pubmed/23406816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.23888
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы